[Progestogens in the treatment of advanced breast cancer. Clinical study of norethisterone acetate].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004361:Drug Tolerance; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006728:Hormones / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009640:Norethindrone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011859:Radiography; D012878:Skin Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D004967:Estrogens; D006728:Hormones; D009640:Norethindrone
Les progestatifs dans le traitement du cancer du sein a une phase avancée. Etude clinique de l'acétate de noréthistérone.